Business Standard

EU in talks with drugmakers to secure potential Covid-19 vaccines: Report

The multiple talks confirm the bloc's more assertive stance on procuring potential Covid-19 shots and drugs after Washington's early moves in securing promising treatments and vaccines

covid, coronavirus, vaccine, drug, pharma
Premium

Asked about the negotiations, Sanofi told Reuters it was in "advanced talks with the EU for the delivery of 300 million doses".

Francesco Guarascio | Reuters Brussels
The European Union is negotiating advance purchase deals of potential Covid-19 vaccines with drugmakers Moderna, Sanofi and Johnson & Johnson and biotech firms BioNtech and CureVac, two EU sources told Reuters.

The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential Covid-19 vaccine, in principle available to all 27 EU nations.

The information on the ongoing talks was shared by the European Commission, the EU executive arm, with EU health ministers at a meeting in Berlin on Thursday, the sources said.

The multiple talks confirm

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 17 2020 | 6:16 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com